| |
| Device | ENLITE SENSOR |
| Generic Name | Automated insulin dosing , threshold suspend |
| Applicant | Medtronic, Inc. 18000 Devonshire St. Northridge, CA 91325 |
| PMA Number | P120010 |
| Supplement Number | S040 |
| Date Received | 10/30/2014 |
| Decision Date | 05/13/2015 |
| Product Code |
OZO |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01112696
|
| Supplement Type | 135 Review Track For 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement APPROVAL FOR A CHANGE IN THE CALCULATION METHOD USED TO DETERMINE THE AMOUNT OF PLATINUM TO ADD IN THE MANUFACTURE OF THE PLATINUM SOLUTION USED IN THE FABRICATION PROCESS FOR THE SOF-SENSOR AND ENLITE SENSORS, AND FOR THE ENLITE SENSOR ONLY, THE ADDITION OF EQUIPMENT USED TO VERIFY THE PLATINUM SOLUTION CONCENTRATION. |
| Post-Approval Study | Show Report Schedule and Study Progress |